Related Experiment Video
Updated: Jun 12, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Blood pressure control in chronic kidney disease: is less really more?
1Division of Nephrology and Hypertension, Department of Medicine, S-2332 Medical Center North, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2372, USA. julia.lewis@vanderbilt.edu
Insights
Blood pressure control is vital for chronic kidney disease patients. Current guidelines suggest a goal of <130/80 mmHg, but benefits require further confirmation from ongoing trials.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Hypertension
Background:
- Blood pressure (BP) management is crucial for patients with chronic kidney disease (CKD).
- Recent guidelines advocate for a stringent BP target of less than 130/80 mmHg for CKD patients.
- The evidence supporting this specific BP goal primarily stems from observational data and subgroup analyses, not definitive randomized trials.
Purpose of the Study:
- To evaluate the established benefits of the <130/80 mmHg blood pressure goal in chronic kidney disease.
- To explore potential adverse events associated with achieving very low blood pressure levels in CKD patients.
Main Methods:
- Review of existing clinical trial data, focusing on randomized, intention-to-treat studies.
- Analysis of observational data and secondary/subgroup findings that informed current guidelines.
- Consideration of emerging evidence regarding potential risks of intensive BP lowering.
Main Results:
- Randomized controlled trials have not conclusively demonstrated the benefits of the <130/80 mmHg BP target in CKD.
- Observational studies and subgroup analyses were key drivers for the updated guideline recommendations.
- Preliminary observations suggest potential risks associated with achieving excessively low BP in this population.
Conclusions:
- The clinical benefits of the <130/80 mmHg BP goal in chronic kidney disease remain to be definitively established by robust randomized trials.
- Further research, including ongoing randomized trials, is necessary to ascertain the true benefits and risks of intensive blood pressure management in CKD.
- A careful balance is needed to optimize BP control while mitigating potential adverse effects in CKD patients.
Abstract:
BP control is critical in the treatment of patients with chronic kidney disease. Recent guidelines now recommend a BP goal of <130/80 mmHg. Clinical trials using a randomized, intention-to-treat design have not established the benefits of this goal; rather, observational data and secondary or subgroup analyses drove the development of the new guidelines. A variety of observations suggest potential adverse events associate with achieving too low a BP in patients with chronic kidney disease, and ongoing randomized trials will have to establish the benefits or risks of meeting this goal.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Chronic Kidney Disease I: Introduction
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Blood Pressure
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
